Sponsor Pipeline

Marcela V. Maus, M.D.,Ph.D. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
5
Recruiting
6
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-08 NCT05020444
TriPRIL CAR T Cells in Multiple Myeloma		 Enrollment closed, study ongoing
2026-08-08 NCT05020444
TriPRIL CAR T Cells in Multiple Myeloma		 Enrollment reduced: 18 -> 16 participants
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Phase 1
3
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06550141 Emapalumab Prevention of CAR-T Cell Associated Toxicities Large B-cell Lymphoma Recruiting
Phase 1/2
NCT07388277 CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis Antineutrophil Cytoplasmic Antibody-associated Vasculitis Recruiting
Phase 1
NCT06026319 CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma Non-hodgkin Lymphoma Recruiting
NCT05660369 CARv3-TEAM-E T Cells in Glioblastoma Glioblastoma Recruiting
NCT05020444 TriPRIL CAR T Cells in Multiple Myeloma Multiple Myeloma Active, Not Recruiting
Not specified
NCT05024175 Long-term Follow-up of Subjects Treated With CAR T Cells Long Term Adverse Effects Recruiting
Disease Areas
Non-Hodgkin Lymphoma (2) Follicular Lymphoma (2) Multiple Myeloma (1) Glioblastoma (1) Glioma (1) Mantle Cell Lymphoma (1)
Get alerts when Marcela V. Maus, M.D.,Ph.D.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free